Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Feasibility Trial to Investigate the Timing of HDR Brachytherapy With EBRT in Intermediate and High Risk Localised Prostate CAncer Patients and Its Effects on Toxicity and Quality of Life

NCT02618161 is registered in ClinicalTrials.gov with Mid and South Essex NHS Foundation Trust as lead sponsor.

NCT NCT02618161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02618161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Feasibility Trial to Investigate the Timing of HDR Brachytherapy With EBRT in Intermediate and High Risk Localised Prostate CAncer Patients and Its Effects on Toxicity and Quality of Life
Lead sponsor
Mid and South Essex NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
November 30, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer